Projections Suggest That Cancer Deaths Will Continue to Rise With an Estimated 9 Million People Dying From Cancer in 2015
Posted on: Tuesday, 26 June 2007, 12:08 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c60597) has announced the addition of Looking at the Cancer Therapy Market to their offering.
Cancer is a disease characterized by a population of cells that grow and divide without respect to normal limits, invade and destroy adjacent tissues, and may spread to distant anatomic sites through a process called metastasis. These life-threatening, malignant properties of cancers differentiate them from benign tumours, which are self-limited in their growth and do not invade or metastasize. Cancer may affect people at all ages, but risk for the more common varieties tends to increase with age. It is one of the principal causes of death in developed countries.
Cancer affects everyone -- the young and old, the rich and poor, men, women and children -- and represents a tremendous burden on patients, families and societies. Cancer is one of the leading causes of death in the world, particularly in developing countries.
Take a look at some hard-hitting facts about this deadly disease:
In 2005, 7.6 million people died of cancer out of 58 million deaths worldwide.
More than 70% of all cancer deaths occur in low and middle income countries, where resources available for prevention, diagnosis and treatment of cancer are limited or nonexistent.
Based on projections, cancer deaths will continue to rise with an estimated 9 million people dying from cancer in 2015, and 11.4 million dying in 2030.
We present a comprehensive research report -- Looking at the Cancer Therapy Market -- which analyzes the global cancer market. Explaining the basics of cancer, to the treatments available and the diagnostic procedures for the disease, the report takes a closer look at the various types of cancer which are prevalent in today's age. The report analyzes the market characteristics of each type of cancer, presenting statistical analysis, theoretical data, and a look at the drug industry for that particular type of cancer.
The report focuses on the leading companies in this segment and what work they are involved in at present in relation to the cancer therapy segment in the global pharmaceutical industry.
Overall, a thorough and complete report looking at the Global Cancer Therapy Market!
A. Executive Summary B. Introduction B.1 What is Cancer? B.2 Historical Perspective of the Disease B.3 Classifying Cancer B.3.1 Nomenclature B.3.2 Adult Cancers B.3.2 Childhood Cancers C. Causes and Pathophysiology of Cancer C.1 Inciting Events C.1.1 Chemical Carcinogens C.1.2 Electromagnetic Radiation C.1.3 Infectious Diseases C.1.4 Hormonal Imbalances C.1.5 Immune System Dysfunction C.1.6 Heredity C.1.7 Other Causes C.2 Looking at Cancer Genetics C.2.1 Oncogenes C.2.2 Tumor Suppressor Genes C.2.3 Types of Genetic Abnormality C.3 Looking at the Biology of a Cancer Cell C.3.1 Malignant Progression C.3.2 Clonal Evolution C.3.3 Biological Properties D. Diagnosing Cancer & Treatment Options D.1 Diagnosis D.1.1 Signs & Symptoms D.1.2 Biopsy D.1.3 Cancer Screening D.2 Treatment of Cancer D.2.1 Surgery D.2.2 Radiation Therapy D.2.3 Chemotherapy D.2.4 Targeted Therapies D.2.5 Immunotherapy D.2.6 Hormonal Therapy D.2.7 Complementary & Alternative Medicines D.2.8 Clinical Trials E. Looking at Brain Cancer E.1 Introduction E.2 Available Treatments E.3 Industry Overview E.4 Industry Growth Drivers E.5 Market Outlook F. Looking at Breast Cancer F.1 Introduction F.2 Available Treatments F.3 Industry Overview F.4 Industry Growth Drivers F.5 Market Outlook G. Looking at Lung Cancer G.1 Introduction G.2 Available Treatments G.3 Industry Overview G.4 Industry Growth Drivers G.5 Market Outlook H. Looking at Leukemia H.1 Introduction H.2 Available Treatments H.3 Industry Overview H.4 Industry Growth Drivers H.5 Market Outlook I. Looking at Prostrate Cancer I.1 Introduction I.2 Available Treatments I.3 Industry Overview I.4 Industry Growth Drivers I.5 Market Outlook J. Analyzing Major Industry Players J.1 AstraZeneca J.2 Bristol-Myers Squibb J.3 GlaxoSmithKline J.4 Novartis J.5 Pfizer J.6 Sanofi Aventis K. Forecast for the Global Cancer Market L. Appendix M. Glossary of Terms
For more information visit http://www.researchandmarkets.com/reports/c60597
Source: Business Wire
Related Articles
- Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018
- Small-Cell Lung Cancer Drug Market Will More Than Double to Over $684 Million in 2017
- High Unmet Need Spurs European Lung Cancer Therapeutics Market
- Generic Erosion of Market Leading Therapies Will Constrain Growth in the Parkinson's Disease Drug Market Over the Next Decade
- Generic Erosion Will Constrain Prostate Cancer Drug Market, Resulting in Annual Growth of Less Than 2 Percent Through 2012
- Key Challenges and Issues Facing the World Music Recording Industry Market
- Cancer Therapeutics Market Could Reach $89 Billion By 2011, Says a New Report Available From Piribo.Com
- The Cancer Cure Coalition Supports the Nomination of Dr. Andrew Von Eschenbach As Commissioner of the U.S. FDA and Calls for the Approval of Advexin, a New Gene Therapy Treatment for Cancer
- Breast Cancer Therapeutics Market Shows Sustained Growth and Opportunity for New Market Participants
- Nokia Sees Multimedia Phones As Major Growth Driver in Asia Pacific
 |
 |
User Comments (0)
RSS Feeds